SRX 0.00% 16.0¢ sierra rutile holdings limited

Ann: Trading Halt, page-44

  1. 598 Posts.
    lightbulb Created with Sketch. 5
    I think we need to keep it in perspective
    After reading some of the comments posted, it is of my own personal opinion that we all see the results very differently maybe because of what we expected from the studies to uncover.....
    Were some of us hoping for a curer, Something to end the threat of a serious disease?
    Anyway for me this was a positive section of the come out of the studies
    “Patients with advanced or inoperable hepatocellular carcinoma have a poor prognosis, often with underlying cirrhosis, and the treatment option currently available, sorafenib, has a high level of toxicity. As cohort studies have demonstrated the efficacy of SIRT with Y-90 resin microspheres, we set out to compare the efficacy of this treatment versus the current standard of care,” said Prof Valérie Vilgrain, Hôpital Beaujon Service de Radiologie, Paris, France, and lead author of the study. “While SIRT demonstrated significantly reduced side effects, better quality of life, higher response rates and more effectively controlled tumour progression in the liver, the overall survival of patients was not higher than in the sorafenib group. Nonetheless, this study provides evidence that SIRT may be a better-tolerated alternative for managing this complex and difficult-to-treat disease, deserving further evaluation.”
    So for those patients that cannot tolerate “sorafenib” because of the higher levels of toxicity, it gives a patient a different choice to better aid and manage their treatment plans that still has some health benefits to ensure a quality of life for them, Therefore I believe this could be just the beginning of something bigger...


    My question for you" whytee" can you see any positive from the results of the studies because surely it's not all bad?...
    Last edited by whatshername: 22/04/17
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $67.91M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $730.9K 4.568M

Buyers (Bids)

No. Vol. Price($)
5 1667096 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 264086 9
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.